Interleukin-6 promoter variants, prostate cancer risk, and survival (Q57265634)

7

Graham G. Giles

0 references

John Hopper

6

John L. Hopper

0 references

Melissa C. Southey

4

Melissa C. Southey

0 references

Dallas R. English

5

Dallas R. English

0 references

Vanessa M Hayes

8

Vanessa M. Hayes

0 references

author name string

Elizabeth A. Tindall

1

0 references

Hoa N. Hoang

Inflammation in prostate carcinogenesis

3

0 references

publication date

10 July 2012

0 references

published in

The Prostate

0 references

volume

72

0 references

issue

16

0 references

page(s)

1701-1707

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

IL-6/IL-6R as a potential key signaling pathway in prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Associations of the -174 G/C interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Interleukin-6 polymorphism is associated with more aggressive prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Polymorphisms inInterleukin-6-6331 Influences the Susceptibility of a Chinese Population to Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Association between periodontitis and common variants in the promoter of the interleukin-6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22557